DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

被引:1917
作者
Geijtenbeek, TBH
Kwon, DS
Torensma, R
van Vliet, SJ
van Duijnhoven, GCF
Middel, J
Cornelissen, ILMHA
Nottet, HSLM
KewalRamani, VN
Littman, DR
Figdor, CG
van Kooyk, Y
机构
[1] Univ Med Ctr St Radboud, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands
[2] Univ Med Ctr St Radboud, Dept Pathol, NL-6525 EX Nijmegen, Netherlands
[3] Univ Utrecht Hosp, Eykman Winkler Inst Microbiol, NL-3584 CX Utrecht, Netherlands
[4] NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA
[5] NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA
关键词
D O I
10.1016/S0092-8674(00)80694-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DC) capture microorganisms that enter peripheral mucosal tissues and then migrate to secondary lymphoid organs, where they present these in antigenic form to resting T cells and thus initiate adaptive immune responses. Here, we describe the properties of a DC-specific C-type lectin, DC-SIGN, that is highly expressed on DC present in mucosal tissues and binds to the HIV-1 envelope glycoprotein gp120. DC-SIGN does not function as a receptor for viral entry into DC but instead promotes efficient infection in trans of cells that express CD4 and chemokine receptors. We propose that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.
引用
收藏
页码:587 / 597
页数:11
相关论文
共 37 条
[1]   A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells [J].
Adema, GJ ;
Hartgers, F ;
Verstraten, R ;
deVries, E ;
Marland, G ;
Menon, S ;
Foster, J ;
Xu, YM ;
Nooyen, P ;
McClanahan, T ;
Bacon, KB ;
Figdor, CG .
NATURE, 1997, 387 (6634) :713-717
[2]   Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors [J].
Ayehunie, S ;
GarciaZepeda, EA ;
Hoxie, JA ;
Horuk, R ;
Kupper, TS ;
Luster, AD ;
Ruprecht, RM .
BLOOD, 1997, 90 (04) :1379-1386
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
BarrattBoyes SM, 1997, J IMMUNOL, V158, P4543
[5]  
Bjorndal A, 1997, J VIROL, V71, P7478
[6]   Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways [J].
Blauvelt, A ;
Asada, H ;
Saville, MW ;
KlausKovtun, V ;
Altman, DJ ;
Yarchoan, R ;
Katz, SI .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :2043-2053
[7]   Dendritic cells and the replication of HIV-1 [J].
Cameron, P ;
Pope, M ;
GranelliPiperno, A ;
Steinman, RM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (02) :158-171
[8]   SUSCEPTIBILITY OF DENDRITIC CELLS TO HIV-1 INFECTION IN-VITRO [J].
CAMERON, PU ;
LOWE, MG ;
CROWE, SM ;
ODOHERTY, U ;
POPE, M ;
GEZELTER, S ;
STEINMAN, RM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) :257-265
[9]   DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS [J].
CAMERON, PU ;
FREUDENTHAL, PS ;
BARKER, JM ;
GEZELTER, S ;
INABA, K ;
STEINMAN, RM .
SCIENCE, 1992, 257 (5068) :383-386
[10]   The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34+ hematopoietic progenitor cells is primarily determined by their maturation stage [J].
Canque, B ;
Bakri, Y ;
Camus, S ;
Yagello, M ;
Benjouad, A ;
Gluckman, JC .
BLOOD, 1999, 93 (11) :3866-3875